Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR6727 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CACTIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4723 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTAFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKAP10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOSR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APEX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RC3H2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF397 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRIPAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDLRAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK1G2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on